Open AccessInhaled Corticosteroid Therapy in Bronchiectasis is Associated with All-Cause Mortality: A Prospective Cohort Study
Author(s) -
Kjell Erik Julius Håkansson,
Katrine Fjællegaard,
Andrea Browatzki,
Melda Dönmez Sin,
Charlotte Suppli Ulrik
Publication year - 2021
Publication title -
international journal of chronic obstructive pulmonary disease/international journal of copd
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 67
eISSN - 1178-2005
pISSN - 1176-9106
DOI - 10.2147/copd.s311236
Subject(s) - medicine , bronchiectasis , copd , concomitant , asthma , cohort , sputum , prospective cohort study , cohort study , lung , pathology , tuberculosis
Prescribing inhaled corticosteroids (ICS) for bronchiectasis (BE) in the absence of obstructive lung disease is controversial. Studies investigating ICS therapy and impact on morbidity and mortality in BE are sparse.